CIK 0001645113
- Large accelerated filer
NovoCure Ltd
Sign in to watch- Ticker
- NVCR
- Exchange
- Nasdaq
- Industry
- Surgical & Medical Instruments & Apparatus
- FY end
- Dec 31
- Entity type
- Operating
- Phone
- +44 1534756700
- Business address
- NO. 4 THE FORUM, GRENVILLE STREET, ST. HELIER, Jersey
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $142,786
- in 3 filings
Net −$142,786. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-02-27 | Puri Michal Nath Chief Human Resources Officer | Sale | −1,162 | $19.92 | $23K | 108,931 |
| 2025-02-27 | Puri Michal Nath Chief Human Resources Officer | Sale | −225 | $20.55 | $5K | 108,706 |
| 2025-02-27 | Leonard Frank X EVP, Pres., Novocure Oncology | Sale | −10,277 | $19.92 | $205K | 150,959 |
| 2025-02-27 | Leonard Frank X EVP, Pres., Novocure Oncology | Sale | −1,989 | $20.55 | $41K | 148,970 |
| 2025-02-27 | Cordova Ashley Chief Executive Officer | Sale | −9,345 | $19.92 | $186K | 210,207 |
| 2025-02-27 | Cordova Ashley Chief Executive Officer | Sale | −1,808 | $20.55 | $37K | 208,399 |
| 2025-02-27 | Paravasthu Mukund Chief Operating Officer | Sale | −1,379 | $19.92 | $27K | 30,058 |
| 2025-02-27 | Paravasthu Mukund Chief Operating Officer | Sale | −267 | $20.55 | $5K | 29,791 |
| 2025-01-11 | Paravasthu Mukund Chief Operating Officer | Sale | −2,160 | $26.81 | $58K | 31,437 |
| 2025-01-01 | Danziger Asaf Director | Grant or award | +400,000 | 415,640 | ||
| 2024-12-31 | Ben Arye Barak General Counsel | Grant or award | +669 | $14.75 | $10K | 118,721 |
| 2024-12-31 | Cordova Ashley Chief Executive Officer | Grant or award | +373 | $14.75 | $6K | 219,552 |
| 2024-12-31 | Danziger Asaf Director | Grant or award | +412 | $14.75 | $6K | 15,640 |
| 2024-11-04 | Paravasthu Mukund Chief Operating Officer | Grant or award | +30,138 | 33,597 | ||
| 2024-11-04 | Paravasthu Mukund Chief Operating Officer | Grant or award · Stock Option (Right to Buy) | +45,620 | $16.59 | $757K | 45,620 |
| 2024-11-02 | Paravasthu Mukund Chief Operating Officer | Sale | −44 | $16.69 | $734 | 3,459 |
| 2024-11-01 | Leonard Frank X EVP, Pres., Novocure Oncology | Sale | −598 | $15.94 | $10K | 161,236 |
| 2024-10-31 | Puri Michal Nath Chief Human Resources Officer | Sale | −810 | $15.79 | $13K | 110,093 |
Page 9 of 9 · 178 trades